Stay updated on ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer
Sign up to get notified when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.

Latest updates to the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page
- Check6 days agoChange DetectedThe page footer now shows Revision: v3.4.3 instead of v3.4.2. This is a minor site update and does not change the study data or visible page content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedVersion 2026-02-13 adds Contacts/Locations and Study Status to the history; the 2026-01-16 entry is removed.SummaryDifference0.2%

- Check34 days agoChange DetectedA new site revision entry (Revision: v3.4.2) was added; the funding-status notice and the earlier Revision: v3.4.1 were removed.SummaryDifference0.3%

- Check41 days agoChange DetectedAdded a government funding status notice and updated the site revision to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.3%

- Check48 days agoChange DetectedGlossary visibility was added and color-coded change highlights were introduced in the history view. The revision label was updated to v3.4.0.SummaryDifference0.3%

- Check55 days agoChange DetectedNew version on 2026-01-16 adds the Study Status and Contacts/Locations sections to the record. The 2025-12-19 version was removed.SummaryDifference0.2%

Stay in the know with updates to ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.